FR2525603B1 - - Google Patents

Info

Publication number
FR2525603B1
FR2525603B1 FR8207203A FR8207203A FR2525603B1 FR 2525603 B1 FR2525603 B1 FR 2525603B1 FR 8207203 A FR8207203 A FR 8207203A FR 8207203 A FR8207203 A FR 8207203A FR 2525603 B1 FR2525603 B1 FR 2525603B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8207203A
Other languages
French (fr)
Other versions
FR2525603A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADIR SARL
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Priority to FR8207203A priority Critical patent/FR2525603A1/fr
Priority to AT0125383A priority patent/ATA125383A/de
Priority to DD83250187A priority patent/DD209833A5/de
Priority to LU84770A priority patent/LU84770A1/fr
Priority to NO831473A priority patent/NO831473L/no
Priority to BE0/210633A priority patent/BE896572A/fr
Priority to KR1019830001753A priority patent/KR840004428A/ko
Priority to PT76595A priority patent/PT76595B/pt
Priority to GR71214A priority patent/GR78481B/el
Priority to JP58073687A priority patent/JPS5910584A/ja
Priority to IL68497A priority patent/IL68497A0/xx
Priority to SE8302347A priority patent/SE8302347L/xx
Priority to ZA832927A priority patent/ZA832927B/xx
Priority to IT48155/83A priority patent/IT1167123B/it
Priority to NL8301476A priority patent/NL8301476A/nl
Priority to AU13953/83A priority patent/AU1395383A/en
Priority to DK183583A priority patent/DK183583A/da
Priority to DE19833315106 priority patent/DE3315106A1/de
Priority to ES521895A priority patent/ES521895A0/es
Priority to OA57984A priority patent/OA07412A/xx
Priority to MA20003A priority patent/MA19783A1/fr
Priority to GB08311508A priority patent/GB2133401B/en
Publication of FR2525603A1 publication Critical patent/FR2525603A1/fr
Application granted granted Critical
Publication of FR2525603B1 publication Critical patent/FR2525603B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FR8207203A 1982-04-27 1982-04-27 Benzoazacycloalkyl-spiro-imidazolinines, leur preparation et leur application en therapeutique Granted FR2525603A1 (fr)

Priority Applications (22)

Application Number Priority Date Filing Date Title
FR8207203A FR2525603A1 (fr) 1982-04-27 1982-04-27 Benzoazacycloalkyl-spiro-imidazolinines, leur preparation et leur application en therapeutique
AT0125383A ATA125383A (de) 1982-04-27 1983-04-08 Verfahren zur herstellung von neuen benzoazacycloalkyl-spiro-imidazolidinen
LU84770A LU84770A1 (fr) 1982-04-27 1983-04-25 Benzoazacycloalkyl-spiro-imidazolidines,leur preparation et leur application en therapeutique
DD83250187A DD209833A5 (de) 1982-04-27 1983-04-25 Verfahren zur herstellung von benzoazacycloalkyl-spiro-imidazolidinen
AU13953/83A AU1395383A (en) 1982-04-27 1983-04-26 Benzoazacycloalkyl-spiro-imidazolidines
KR1019830001753A KR840004428A (ko) 1982-04-27 1983-04-26 벤조 아자시클로 알킬-스피로-이미다졸리딘의 제조방법
PT76595A PT76595B (fr) 1982-04-27 1983-04-26 Procede de preparation de benzoazacycloalkyl-spiro-imidazolidines
GR71214A GR78481B (OSRAM) 1982-04-27 1983-04-26
JP58073687A JPS5910584A (ja) 1982-04-27 1983-04-26 イミダゾリジン誘導体
IL68497A IL68497A0 (en) 1982-04-27 1983-04-26 Benzoazacycloalkyl-spiro-imidazolidines,their preparation and pharmaceutical compositions containing them
NO831473A NO831473L (no) 1982-04-27 1983-04-26 Fremgangsmaate ved fremstilling av benzoazacykloalkyl-spiro-imidazolidiner
ZA832927A ZA832927B (en) 1982-04-27 1983-04-26 Benzoazacycloalkyl-spiro-imidazolidines,their preparation and compositions containing them
IT48155/83A IT1167123B (it) 1982-04-27 1983-04-26 Benzoazacicloalchilspiro-imidazolidine,procedimento per prepararle e composizioni farmaceutiche che le contengono
NL8301476A NL8301476A (nl) 1982-04-27 1983-04-26 Benzoazacycloalkylspiroimidazolidines, hun bereiding en farmaceutische samenstellingen welke deze bevatten.
BE0/210633A BE896572A (fr) 1982-04-27 1983-04-26 Benzoazacycloalkyl-spiro-imidazolidines leur preparation et leur application en therapeutique
DK183583A DK183583A (da) 1982-04-27 1983-04-26 Fremgangsmaade til fremstilling af benzoazacycloalkyl-spiro-imidazolidiner
SE8302347A SE8302347L (sv) 1982-04-27 1983-04-26 Bensoazacykloalkyl-spiro-imidazolidiner, framstellning derav och farmaceutiska kompositioner innehallande dem
DE19833315106 DE3315106A1 (de) 1982-04-27 1983-04-27 Benzoazacycloalkyl-spiro-imidazolidine, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen
ES521895A ES521895A0 (es) 1982-04-27 1983-04-27 Procedimiento de preparacion de benzoazacicloalquil-espiroimidazolidina, asi como de sus sales obtenidas con bases minerales u organicas farmaceuticamente aceptables.
OA57984A OA07412A (fr) 1982-04-27 1983-04-27 Benzoazacycloalhyl-spiro-imidazolidines leur préparation et leur application en thérapeutique.
MA20003A MA19783A1 (fr) 1982-04-27 1983-04-27 Procede de preparation de benzoazacycloalkyl-spiro-imidazolidines.
GB08311508A GB2133401B (en) 1982-04-27 1983-04-27 Benzoazacycloalkyl-spiro-imidazolidines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8207203A FR2525603A1 (fr) 1982-04-27 1982-04-27 Benzoazacycloalkyl-spiro-imidazolinines, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
FR2525603A1 FR2525603A1 (fr) 1983-10-28
FR2525603B1 true FR2525603B1 (OSRAM) 1984-09-14

Family

ID=9273425

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8207203A Granted FR2525603A1 (fr) 1982-04-27 1982-04-27 Benzoazacycloalkyl-spiro-imidazolinines, leur preparation et leur application en therapeutique

Country Status (22)

Country Link
JP (1) JPS5910584A (OSRAM)
KR (1) KR840004428A (OSRAM)
AT (1) ATA125383A (OSRAM)
AU (1) AU1395383A (OSRAM)
BE (1) BE896572A (OSRAM)
DD (1) DD209833A5 (OSRAM)
DE (1) DE3315106A1 (OSRAM)
DK (1) DK183583A (OSRAM)
ES (1) ES521895A0 (OSRAM)
FR (1) FR2525603A1 (OSRAM)
GB (1) GB2133401B (OSRAM)
GR (1) GR78481B (OSRAM)
IL (1) IL68497A0 (OSRAM)
IT (1) IT1167123B (OSRAM)
LU (1) LU84770A1 (OSRAM)
MA (1) MA19783A1 (OSRAM)
NL (1) NL8301476A (OSRAM)
NO (1) NO831473L (OSRAM)
OA (1) OA07412A (OSRAM)
PT (1) PT76595B (OSRAM)
SE (1) SE8302347L (OSRAM)
ZA (1) ZA832927B (OSRAM)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU617541B2 (en) * 1988-10-20 1991-11-28 Wyeth Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
US4927831A (en) * 1988-10-20 1990-05-22 American Home Products Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
US6953787B2 (en) 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
CN101274911B (zh) 2003-06-17 2011-01-26 艾尼纳制药公司 用于治疗5ht2c受体相关病症的苯并氮杂卓衍生物
MXPA05013364A (es) 2003-06-17 2006-03-17 Arena Pharm Inc Procedimiento para preparar 3-benzazepinas.
ATE442359T1 (de) 2004-12-21 2009-09-15 Arena Pharm Inc Kristalline formen von (r)-8-chlor-1-methyl-2,3,4,5-tetrahydro-1h-3-be zazepinhydrochlorid
EP1833473B1 (en) 2004-12-23 2009-09-09 Arena Pharmaceuticals, Inc. 5ht2c receptor modulator compositions and methods of use
CN101466684B (zh) 2006-04-03 2012-06-20 艾尼纳制药公司 8-氯-1-甲基-2,3,4,5-四氢-1h-3-苯并氮杂卓的制备工艺和其相关中间体
CN101547892B (zh) 2006-12-05 2014-08-20 艾尼纳制药公司 制备(r)-8-氯-1-甲基-2,3,4,5-四氢-1h-3-苯并氮杂卓的方法和其中间体
US8822727B2 (en) 2008-03-04 2014-09-02 Arena Pharmaceuticals, Inc. Processes for the preparation of intermediates related to the 5-HT2C agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
WO2010148207A2 (en) 2009-06-18 2010-12-23 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-ht2c receptor agonists
US9045431B2 (en) 2010-06-02 2015-06-02 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
AU2011296033A1 (en) 2010-09-01 2013-04-04 Arena Pharmaceuticals, Inc. Non-hygroscopic salts of 5-HT2C agonists
JP6272695B2 (ja) 2010-09-01 2018-01-31 エーザイ・アール・アンド・ディー・マネジメント株式会社 体重管理のために有用な５−ｈｔ２ｃアゴニストの改変放出剤形
BR112013004707A2 (pt) 2010-09-01 2016-05-10 Arena Pharm Inc administração de um composto antiobesidade a indivíduos com comprometimento renal
SG10201506870PA (en) 2010-09-01 2015-10-29 Arena Pharm Inc Salts of lorcaserin with optically active acids
BR112015007779A2 (pt) 2012-10-09 2017-07-04 Arena Pharm Inc célula de fluxo de permeabilidade e sistema de condutância hidráulica

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4209630A (en) * 1976-10-18 1980-06-24 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4235911A (en) * 1979-06-13 1980-11-25 Pfizer Inc. Hydantoin derivatives

Also Published As

Publication number Publication date
PT76595B (fr) 1986-01-21
NL8301476A (nl) 1983-11-16
OA07412A (fr) 1984-11-30
FR2525603A1 (fr) 1983-10-28
ES8405796A1 (es) 1984-06-16
GB2133401A (en) 1984-07-25
KR840004428A (ko) 1984-10-15
ZA832927B (en) 1984-06-27
IT1167123B (it) 1987-05-13
ATA125383A (de) 1986-05-15
NO831473L (no) 1983-10-28
GR78481B (OSRAM) 1984-09-27
JPS5910584A (ja) 1984-01-20
MA19783A1 (fr) 1983-12-31
IL68497A0 (en) 1983-07-31
GB8311508D0 (en) 1983-06-02
LU84770A1 (fr) 1984-11-28
PT76595A (fr) 1983-05-01
SE8302347D0 (sv) 1983-04-26
IT8348155A0 (it) 1983-04-26
GB2133401B (en) 1985-10-23
SE8302347L (sv) 1983-10-28
DK183583D0 (da) 1983-04-26
DE3315106A1 (de) 1983-11-03
BE896572A (fr) 1983-10-26
DK183583A (da) 1983-10-28
AU1395383A (en) 1983-11-03
DD209833A5 (de) 1984-05-23
ES521895A0 (es) 1984-06-16

Similar Documents

Publication Publication Date Title
DE3374522D1 (OSRAM)
FR2520091B1 (OSRAM)
DE3347807A1 (OSRAM)
DK8504588A (OSRAM)
CH655644B (OSRAM)
DE3212223C2 (OSRAM)
CH655690B (OSRAM)
DE3382599D1 (OSRAM)
DE3311835C2 (OSRAM)
FR2525603B1 (OSRAM)
FR2521244B1 (OSRAM)
FR2519301B1 (OSRAM)
FR2519393B1 (OSRAM)
FR2519556B3 (OSRAM)
DE3347918A1 (OSRAM)
FR2522201B1 (OSRAM)
CH665521GA3 (OSRAM)
FR2519723B3 (OSRAM)
DE3210155C2 (OSRAM)
FR2519749B1 (OSRAM)
FR2525020B1 (OSRAM)
FR2519252B3 (OSRAM)
FR2519849B1 (OSRAM)
FR2519591B1 (OSRAM)
FR2521035B1 (OSRAM)

Legal Events

Date Code Title Description
ST Notification of lapse